🔥Telegram İfşa

Recorded lectures from the LA/ER Antiretroviral Research Resource Program (LEAP) Investigator Meeting and Annual Workshop - 2018 are now available -- bit.ly/2wvgExP

CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI) 2019, Seattle, Washington - March 4-7, 2019. Visit our EVENTS page - bit.ly/2POTQC1

10TH INTERNATIONAL AIDS SOCIETY CONFERENCE ON HIV SCIENCE (IAS 2019), Seattle, Washington - July 21-24, 2019. Visit our EVENTS page - bit.ly/2POTQC1

Recordings from the 2019 Long-Acting/Extended Release Antiretroviral Research Resource Program Investigator Meeting & Annual Workshop are now available - bit.ly/2u5NLHK

Recent Publication: The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth. bit.ly/2CobTK9

EVENTS: 10TH International AIDS Society Conference on HIV Science (IAS 2019) - bit.ly/2HkTAcX

Recent Publication: Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies. go.nature.com/2Vb19WM

Recent Publication: Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV bit.ly/2J7ohlV #ccghe

Recent Publication: Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities. bit.ly/2M99ucP #ccghe

Recent Publication: Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective. bit.ly/2kGJFol

Now Available: Recordings from the 2020 Long-Acting/Extended Release Antiretroviral Research Resource Program Investigator Meeting & Annual Workshop, which took place Saturday, March 7, 2020 at Boston Marriott Copley Place in Boston, MASS. longactinghiv.org/content/long-a…

Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed) longactinghiv.org/content/long-a…

PRESS RELEASE: Long-acting injectable cabotegravir is highly effective for the prevention of HIV infection in cisgender men and transgender women who have sex with men - bit.ly/3cJLM0j

Recent Publication: The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modelling Study - bit.ly/2ALG6oy

Recent Publications: Pharmacokinetics, Safety and Tolerability of Long-Acting Parenteral Intramuscular Injection Formulations of Doravirine - bit.ly/2APB36F

Recent Publication: Predicting pharmacokinetics of a tenofovir alafenamide subcutaneous implant using PBPK modelling - bit.ly/3cWTYtp

Recorded lectures from the LA/ER Antiretroviral Drugs Workshop 2016 -- tinyurl.com/LE-AR2016

Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Tx - tinyurl.com/jhhz2o2

Recorded lectures from the LA/ER Antiretroviral Drugs Workshop 2017 -- tinyurl.com/LA-ER2017 are now available.

Injectable implant for long-acting HIV/AIDS prevention receives funding - tinyurl.com/ltmxluk